» Authors » Joseph Batta-Mpouma

Joseph Batta-Mpouma

Explore the profile of Joseph Batta-Mpouma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 12
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Batta-Mpouma J, Kandhola G, Kaur J, Foley K, Walters K, Kotagiri N, et al.
Carbohydr Polym . 2025 Mar; 356:123355. PMID: 40049949
Controlled release systems (CRSs) have been sought after as a compelling platform for site-specific delivery of bioactive compounds (BCs), including traditional drugs and food supplements. However, their potential is often...
2.
Batta-Mpouma J, Kandhola G, Kim J
Sci Rep . 2023 Dec; 13(1):21630. PMID: 38062088
Biologically extracted cellulose nanocrystals (CNCs) are rod-like and amphiphilic materials with surface-exposed (hydrophilic sites) and hidden (hydrophobic sites) hydroxyl groups. These physicochemical characteristics make CNCs suitable for use as emulsifying...
3.
Poudel H, RanguMagar A, Singh P, Oluremi A, Ali N, Watanabe F, et al.
Bioengineering (Basel) . 2023 Sep; 10(9). PMID: 37760190
Injectable hydrogels offer numerous advantages in various areas, which include tissue engineering and drug delivery because of their unique properties such as tunability, excellent carrier properties, and biocompatibility. These hydrogels...
4.
Batta-Mpouma J, Kandhola G, Sakon J, Kim J
Biomacromolecules . 2022 Sep; 23(10):4085-4096. PMID: 36166819
Cellulose nanocrystals (CNCs) have shown promise for the development of multifunctional materials for many research communities, ranging from bioresource engineering and biomedical engineering to materials science and engineering. However, accessible...
5.
Sakamaki Y, Ozdemir J, Heidrick Z, Azzun A, Watson O, Tsuji M, et al.
ACS Appl Bio Mater . 2021 Aug; 4(2):1432-1440. PMID: 34337346
The field of photodynamic therapy (PDT) has continued to show promise as a potential method for treating tumors. In this work a photosensitizer (PS) has been delivered to cancer cell...
6.
Sakamaki Y, Ozdemir J, Diaz Perez A, Heidrick Z, Watson O, Tsuji M, et al.
Adv Ther (Weinh) . 2020 Oct; 3(8). PMID: 33072859
Herein, we report a nano-MOF conjugated to maltotriose as a new DDS. MA-PCN-224-0.1Mn/0.9Zn showed its ability to target cancer and TAM. This novel MOF is an effective PDT agent and...